The WFH's Clinical Research Grant Program provides support for international clinical investigation relating to inherited bleeding disorders.
The aim is to help create better evidence for the clinical management of hemophilia A and B, von Willebrand disease, rare factor deficiencies, and inherited platelet disorders. The program is peer reviewed and is open to researchers globally.
The WFH Clinical Research Grant Program will award up to four grants (two in each category) per year for the best proposals that address critical clinical issues of broad international significance.
Deadline for Letter of Intent: Aug. 31, 2015
The Grant Program is open to applicants from all countries who are affiliated with a recognized medical, scientific, or academic institution*, hemophilia or inherited bleeding disorder treatment centre, or WFH National Member Organization (NMO) or its affiliated chapters.
*PhD students are not eligible; the principle investigator must hold a faculty position at a recognized medical, scientific, or academic institution.
There are two levels of funding available:
Funding is awarded for up to two years.
